Clinical Trial Update: The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer [NA]

View source ↗

Summary

This trial update describes the biodistribution and potential diagnostic use of the PET tracer 18F FACBC in patients with breast cancer, head and neck cancer, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Cancer
• Prostate Cancer

Drugs mentioned

• Fluciclovine F-18 (FACBC) (fluciclovine F-18)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Head and Neck Cancer | NA | Status: COMPLETED